HAPPY ANNIVERSARY TO MOVEX CLINICS! We are very happy to know that we have been making a big difference in our patients' lives for the past two years. As experts in neuro-rehabilitation with exoskeletons, we have proven that it is possible to go beyond conventional treatments and achieve unique results in less time.
At Movex Clinics, we specialise in the treatment of various pathologies, including:
Stroke: both ischaemic and haemorrhagic, as well as traumatic brain injury.
Spinal cord injury: from traumatic injuries and tumours to myelopathies and other spinal cord injuries.
Post-operative: we offer rehabilitation of knee injuries for faster recovery.
Neurodegenerative diseases: Parkinson's, Multiple Sclerosis (MS) and Amyotrophic Lateral Sclerosis (ALS).
Neuromuscular diseases: Ataxia, muscular dystrophies and Spinal Muscular Atrophy (SMA).
Cerebral palsy.
Brain or central nervous system tumours.
Peripheral nervous system injuries.
With more than 100 rehabilitated patients, we have revolutionised neurological rehabilitation, providing advanced and personalised therapy for each patient. Thanks to our technology and our focus on neuro-plasticity and motor neuron reprogramming through repetitive motion, we have been able to help people regain their mobility and improve their quality of life.
Not surprisingly, we have achieved great success in such a short time. We are proud to be the only biomedical exoskeleton manufacturer to offer in-house therapies in our clinics. We also have a Living Lab in Urretxu where we research, design and develop unique and personalised treatments. Nobody knows the robotic neurorehabilitation method better than we do.
In fact, our innovative therapies are leading the way in neurorehabilitation, providing an effective and efficient alternative to conventional treatments. We are confident that we will continue to be leaders in the field for years to come.
Congratulations on our second anniversary and all that we have achieved so far! We are excited to see what the future holds and look forward to continuing to see how we transform lives.
Comments